Considering that approximately 10–15% of all human cancers activate ALT pathways to maintain telomeres [44, 45] and that ALT was recently shown to occur even in normal mammalian somatic cells in vivo [46], our results may be relevant in understanding how Swi1Timeless ensures telomere stability and prevents ALT activation in subsets of human cancers. This evidence concerns the gene GPT and cancer.